{"schema_version":"secwatch.filing_event.v1","accession":"0001770787-24-000007","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.471337+00:00","generated_at":"2026-06-06T23:22:00.045615+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CCO James Wilbur to depart 10x Genomics on Feb 1, 2024; gets severance","bullets":["James Wilbur, Chief Commercial Officer, leaving effective Feb 1, 2024; no disagreement with management.","Severance: six months base salary plus one-time COBRA payment of $14,335.","No 2023 annual performance bonus for Wilbur.","Departure not related to company's operations, financial statements, or policies."],"urls":{"canonical":"https://secwatch.observer/filing/0001770787-24-000007","json":"https://secwatch.observer/filing/0001770787-24-000007.json","markdown":"https://secwatch.observer/filing/0001770787-24-000007.md","text":"https://secwatch.observer/filing/0001770787-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000177078724000007/0001770787-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000177078724000007/txg-20240115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:22:00.045615+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a424b8420","claim":"James Wilbur departed as Chief Commercial Officer at 10x Genomics, Inc..","evidence_excerpt":"On January 15, 2024, Chief Commercial Officer James Wilbur and 10x Genomics, Inc. (the “Company”) entered into a Transition and Separation Agreement (the “Agreement”) pursuant to which Dr. Wilbur will depart the Company on February 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770787/000177078724000007/0001770787-24-000007-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}